期刊
JOURNAL OF THE NEUROLOGICAL SCIENCES
卷 300, 期 1-2, 页码 52-58出版社
ELSEVIER
DOI: 10.1016/j.jns.2010.09.034
关键词
Low-dose; Endothelial monocyte-activating; polypeptide-II; Blood-tumor barrier; Permeability; alpha subunit of ATP synthase; Functional target
资金
- Natural Science Foundation of China [30670723, 30700249, 30700861, 30800451, 30872656, 30973079]
- Natural Science Foundation of Liaoning Province in China [20082102]
- Educational Department of Liaoning Province [2008850]
- Shenyang Science and Technology Plan Projects [1091175-1-01, 1081266-9-00]
This study was performed to determine whether the a subunit of ATP synthase (alpha-ATP synthase) on brain microvascular endothelial cells (BMECs) serves as the functional target for endothelial monocyte-activating polypeptide-II (EMAP-II)-induced increase in blood-tumor barrier (BIB) permeability. Using a rat CO glioma model, we found that low-dose (80 ng/kg) EMAP-Il significantly decreased the mRNA and protein expression levels of tight junction (TJ)-related proteins claudin-5, occludin, and ZO-1 on BMECs. Meantime. radioimmunity and Western blot assay she-red a significant decrease in the expression levels of cAMP and catalytic subunit of protein kinase A (PKAcs) of tumor tissues. Also, pretreatment with specific a-ATP synthase antibody significantly blocked the effects of EMAP-II on TJ-related proteins, cAMP, and PKAcs. In addition, double immunofluorescence assay identified that EMAP-II was co-localized with a-ATP synthase on BMECs. This in vivo study demonstrated that a subunit of ATP synthase on BMECs serves as the functional target for EMAP-Il selective opening of the BTB, and that cAMP/PKA signaling transduction pathway might be involved in the modulating process. (c) 2010 Elsevier B.V. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据